Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2002
03/07/2002US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis
03/07/2002US20020028842 Reducing the vomiting side effects of phosphodiesterase inhibitors, e.g. Rolipram, Ariflo, by benzylation by benzyl bromide or a derivative
03/07/2002US20020028833 Aryl alkenamides derivatives as mcp-1 antagonists
03/07/2002US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
03/07/2002US20020028818 2-nitrostyryl-1-(naphthylmethyl)sulfone for example
03/07/2002US20020028799 Using protease and phospodiesterase inhibitor
03/07/2002DE10041903A1 New aconitic acid derivatives useful as ultraviolet absorbers, fluorescent dyes, marker dyes, optical brighteners and intermediates for pharmaceutical, veterinary or plant protection agents
03/07/2002CA2383855A1 Dyes for keratin fibers, the dyes containing n-benzyl-p-phenylenediamine derivatives and novel n-benzyl-p-phenylenediamine derivatives
03/06/2002EP1184372A1 Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs)
03/06/2002EP1184370A2 Compounds with growth hormone releasing properties
03/06/2002EP1184358A2 Process for treatment and purification of the reaction products obtained by reduction with lithium aluminium hydride
03/06/2002EP1183238A1 Metabotropic glutamate receptor antagonists
03/06/2002EP1183235A2 INHIBITORS OF FACTOR Xa
03/06/2002EP0883403A4 Method for treating sexual dysfunctions
03/06/2002CN1339032A Reverse hydroxamate inhibitors of matrix metalloproteinases
03/06/2002CN1080258C 1-H-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
03/06/2002CN1080257C Guanidine derivatives
03/05/2002US6353099 Substituted ureas as cell adhesion inhibitors
03/05/2002US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents
03/05/2002US6353016 Pyrrole compounds for potassium channel activators
03/05/2002US6353004 Peripherally acting anti-pruritic opiates
03/05/2002US6352977 Substituted β-alanines
03/05/2002US6352566 Ethers of polyalkyl or polyalkenyl N-hydroxyalkyl succinimides and fuel compositions containing the same
03/05/2002CA2206122C Arylacrylamide derivatives
02/2002
02/28/2002WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2002016313A2 Integrin receptor inhibitors
02/28/2002WO2001083447A3 A halopyrrole ligand for use in a catalyst system
02/28/2002WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
02/28/2002WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
02/28/2002WO2001068600A3 Benzylated pde4 inhibitors
02/28/2002WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents
02/28/2002WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/28/2002US20020026074 Process and intermediate compounds for the preparation of pyrrolidines
02/28/2002US20020026073 Process and intermediate compounds for the preparation of pyrrolidines
02/28/2002US20020026072 From tri-O-acetyl-D-erythro-4-pentulosonic acid esters
02/28/2002US20020026071 From tri-O-acetyl-D-erythro-4-pentulosonic acid esters
02/28/2002US20020026055 Aminopyridine-containing thiourea inhibitors of herpes viruses
02/28/2002US20020026034 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
02/28/2002US20020025980 Single morphic forms of metalloproteinase inhibitors
02/28/2002CA2419580A1 Integrin receptor inhibitors
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/27/2002EP1182183A1 Anthracene derivatives and organic electroluminescent devices made by using the same
02/27/2002EP1181287A1 Sulfonamide compounds with pharmaceutical activity
02/27/2002EP1181274A1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
02/27/2002EP1181270A2 Inhibitors of factor xa
02/27/2002EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
02/27/2002EP1181005A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same
02/27/2002EP0790982B1 Methods of synthesis of peptidyl argininals
02/27/2002CN1337953A New thryoid receptor ligands and process II
02/27/2002CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors
02/27/2002CN1337941A Amide derivatives
02/27/2002CN1079793C Process for preparation of enantiomerically pure substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
02/27/2002CN1079792C 酶抑制剂 Inhibitors
02/27/2002CN1079638C Fungicidal mixture
02/26/2002US6350904 Method for producing ortho-alkylated benzoic acid derivatives
02/26/2002US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
02/26/2002US6350883 Method for preparing lactam
02/26/2002US6350882 Synthesis of substituted prolines
02/26/2002CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present
02/26/2002CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent
02/26/2002CA2046801C Substituted pyrroles
02/21/2002WO2002014332A1 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts
02/21/2002WO2002014271A1 Proline derivatives and use thereof as drugs
02/21/2002WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors
02/21/2002WO2002014267A1 Novel aminocyclohexane derivatives
02/21/2002WO2001072960A3 Il-8 receptor antagonists
02/21/2002WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof
02/21/2002WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
02/21/2002WO2001046110A3 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
02/21/2002US20020022614 Thrombin or factor Xa inhibitors
02/21/2002US20020022612 Nitrogen containing heterocyclic compounds useful as anticoagulants
02/21/2002US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists
02/21/2002US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them
02/21/2002US20020022575 Dialkyl-halogenophenyl-substituted ketoenols
02/20/2002EP1180513A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
02/20/2002EP1180512A1 Fungicidal phenylimine derivatives
02/20/2002EP1180366A1 Neuronal death inhibitors
02/20/2002EP1180097A1 Mutual salt of amlodipine and atorvastatin
02/20/2002CN1336930A Bridged heterocyclic derivatives
02/20/2002CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
02/20/2002CN1336356A Method for prepn. of alkaline organic nitrogen-contg. compound by using aluminium lithium oxide reduction method
02/20/2002CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
02/20/2002CN1079396C Aromatic amidine derivatives useful as selective thrombin inhibitors
02/19/2002USRE37556 Superoxide radical inhibitor
02/19/2002US6348602 Cyclic AMP-specific phosphodiesterase inhibitors
02/19/2002US6348601 Preparation of N-methyl-2-pyrrolidone (NMP)
02/19/2002US6348600 Cyclizing optically active asparagine ester derivative or acid salt thereof by dissolving compound in solvent
02/19/2002US6348551 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
02/19/2002US6348489 Method of treating traumatic brain injury and other neuronal disorders
02/19/2002US6348464 Pyrrolecarbonylimino derivatives as naaladase inhibitors
02/19/2002CA2017217C Amino acid derivative anticonvulsant
02/14/2002WO2002012224A2 Bicyclic compounds as h3 receptor ligands
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
02/14/2002WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002WO2002012178A1 Compounds acting as melanocortin receptor ligands
02/14/2002WO2002012167A1 Novel araquidonic acid derivatives with affinity toward the anandamide transporter
02/14/2002WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same
02/14/2002WO2001062087A3 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants